Document Detail


Soluble ST2 predicts elevated SBP in the community.
MedLine Citation:
PMID:  23615326     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Soluble ST2 (sST2) is an emerging prognostic biomarker in patients with existing cardiovascular disease. ST2 and its ligand, interleukin-33 (IL-33), are expressed in endothelial cells, and may play an important role in the development of early atherosclerosis and vascular biology. We sought to investigate the association of sST2 and progression of blood pressure (BP), as well as the development of hypertension.
METHODS: Circulating sST2 concentrations were measured in 1834 participants (mean age 56 years, 57% women) of the community-based Framingham Offspring study. Participants were free of hypertension at baseline. Multivariable linear and logistic regression models were used to evaluate the association of sST2 concentrations and subsequent BP outcomes.
RESULTS: Higher sST2 concentrations were associated with incident hypertension over 3 years of follow-up [multivariable-adjusted odds ratio per 1 standard deviation increase in sST2 1.22, 95% confidence interval 1.05-1.42, P=0.01]. Individuals in the upper sST2 quartile had a 2.6 mmHg greater increase in SBP compared with those in the lowest quartile (P for trend across quartiles 0.002) and a 1.8 mmHg greater increase in pulse pressure (P for trend 0.005). In contrast, sST2 concentrations were not associated with changes in DBP (P=0.27).
CONCLUSION: These findings suggest that sST2 concentrations predict changes in BP physiology typically seen with aging and progressive arterial stiffness. Further studies are needed to elucidate underlying mechanisms by which the ST2/IL-33 pathway may contribute to BP physiology.
Authors:
Jennifer E Ho; Martin G Larson; Anahita Ghorbani; Susan Cheng; Ramachandran S Vasan; Thomas J Wang; James L Januzzi
Related Documents :
6578766 - Effects of sympathetic nerve activity on changes in the position of the rabbit incisor ...
20826706 - Ventilatory restraint of sympathetic activity during chemoreflex stress.
1364056 - Correlation of cardiovascular and respiratory responses to glutamate excitation of pres...
920216 - Cardiac receptors activated during the hypothalamic defence reaction.
8983876 - Chronic sodium-potassium-atpase inhibition with ouabain impairs renal haemodynamics and...
16629686 - Cardiorespiratory fitness and laboratory stress: a meta-regression analysis.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of hypertension     Volume:  31     ISSN:  1473-5598     ISO Abbreviation:  J. Hypertens.     Publication Date:  2013 Jul 
Date Detail:
Created Date:  2013-09-05     Completed Date:  2014-02-10     Revised Date:  2014-04-15    
Medline Journal Info:
Nlm Unique ID:  8306882     Medline TA:  J Hypertens     Country:  England    
Other Details:
Languages:  eng     Pagination:  1431-6; discussion 1436     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Biological Markers / blood*
Female
Humans
Hypertension / blood*
Male
Middle Aged
Receptors, Cell Surface / blood*
Systole*
Grant Support
ID/Acronym/Agency:
N01-HC-25195/HC/NHLBI NIH HHS; N01HC25195/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Biological Markers; 0/IL1RL1 protein, human; 0/Receptors, Cell Surface
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Increased wave reflection and ejection duration in women with chest pain and nonobstructive coronary...
Next Document:  Circulating biomarkers of collagen metabolism in arterial hypertension: relevance of target organ da...